Summary
This comprehensive review, published in Signal Transduction and Targeted Therapy, examines the role of energy metabolism in maintaining physiological homeostasis and its dysregulation in a range of chronic and metabolic diseases. It likely synthesises current mechanistic understanding of key metabolic pathways — including mitochondrial respiration, glycolysis, and lipid metabolism — and how their impairment underpins conditions such as diabetes, cancer, and neurodegeneration. The paper presumably also surveys emerging therapeutic targets within these pathways, reflecting the journal's focus on translational biomedical research.
UK applicability
Whilst this review is not specific to the UK, its findings are broadly applicable to UK clinical practice and public health policy given the high burden of metabolic diseases such as type 2 diabetes and obesity in the UK population; insights into energy metabolism targets may inform NHS treatment strategies and NICE guideline development.
Key measures
Metabolic pathway activity (glycolysis, oxidative phosphorylation, fatty acid oxidation); mitochondrial function; ATP production; disease biomarkers associated with metabolic dysfunction
Outcomes reported
The review likely examines how disruptions to cellular and systemic energy metabolism contribute to diseases such as obesity, type 2 diabetes, cancer, and cardiovascular conditions, and surveys potential therapeutic strategies targeting metabolic pathways.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.